Robert Dagil

11PUBLICATIONS
80CO-AUTHORS
Molecular targetsGlycoconjugatesMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersDevelopmental genetics (incl. sex determination)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 24, 2026
Preclinical profiling of antibody drug conjugates targeting oncofetal chondroitin sulfate.

Ann Skafte, Elena Ethel Vidal-Calvo, Swati Choudhary

|Dec 17, 2025
The glycosaminoglycan oncofetal chondroitin sulfate is a novel target for antibody-drug conjugate therapy for AML.

Joana Mujollari, Montserrat Estruch, Priya Khadgawat

|Oct 15, 2024
Transient CAR T cells with specificity to oncofetal glycosaminoglycans in solid tumors.

Nastaran Khazamipour, Htoo Zarni Oo, Nader Al-Nakouzi

|Oct 01, 2024
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages.

Melanie R Walker, Alexander Underwood, Kasper H Björnsson

|Aug 30, 2024
Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate.

Elena Ethel Vidal-Calvo, Anne Martin-Salazar, Swati Choudhary

|Aug 13, 2022
Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer.

Nader Al-Nakouzi, Chris Kedong Wang, Htoo Zarni Oo

Pageof 2

Frequent Collaborators

5 joint publications

Ali Salanti

5 joint publications

Elena Vidal Calvo

4 joint publications

Mads Daugaard

4 joint publications

Morten A Nielsen